Study on CYP2C19*2, CYP2C19*3 gene polymorphisms in ischemic stroke patients and treatment results at S.I.S Can Tho International Hospital
In the afternoon of May 25, 2023, Can Tho city Department of Science and Technology held a meeting to select organizations and individuals to implement the science and technology project "Research on CYP2C19*2, CYP2C19*3 gene polymorphisms in patients with ischemic stroke and treatment results at S.I.S Can Tho international general hospital.” Council led by Dr. Ngo Anh Tin, Director of the Department of Science and Technology as Chairman of the Council. Dr. Tran Chi Cuong and Dr. Nguyen Tran Tran co-carry. S.I.S Can Tho International General Hospital is an implementing organization.
.jpg)
Overview of the meeting
The objective of the study is to investigate CYP2C19*2, CYP2C19*3 gene polymorphisms in ischemic stroke patients and evaluate the effectiveness and safety between the combination of Ticagrelor - Aspirin compared with Clopidogrel - Aspirin based on the genotype CYP2C19 in stroke patients treated in Can Tho city, clarifying treatment regimens for each group.

Council's memebers
.jpg)
.jpg)
Research team
.jpg)
Chairman of the Council concluded the meeting
.jpg)
The Chairman of the Council, members and the research team took souvenir photos
The Council came up with some suggestions for the research team to edit and complete their presentation.
Can Tho City Department of Science and Technology